Cargando…
AP-1 controls the p11-dependent antidepressant response
Selective serotonin reuptake inhibitors (SSRIs) are the most widely prescribed drugs for mood disorders. While the mechanism of SSRI action is still unknown, SSRIs are thought to exert therapeutic effects by elevating extracellular serotonin levels in the brain, and remodel the structural and functi...
Autores principales: | Chottekalapanda, Revathy U., Kalik, Salina, Gresack, Jodi, Ayala, Alyssa, Gao, Melanie, Wang, Wei, Meller, Sarah, Aly, Ammar, Schaefer, Anne, Greengard, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303013/ https://www.ncbi.nlm.nih.gov/pubmed/32439846 http://dx.doi.org/10.1038/s41380-020-0767-8 |
Ejemplares similares
-
Mapping the physiological and molecular markers of stress and SSRI antidepressant treatment in S100a10 corticostriatal neurons
por: Sargin, Derya, et al.
Publicado: (2019) -
FRI359 Postprandial Hypoglycemia With Elevated Pro-insulin As A Rare Presentation Of Insulinoma
por: Kalik, Salina, et al.
Publicado: (2023) -
FRI262 Can Selective Serotonin Reuptake Inhibitors Unmask Underlying Polyglandular Autoimmune Syndrome Type II?
por: Dehghani, Shabnam, et al.
Publicado: (2023) -
Activation of the p11/SMARCA3/Neurensin-2 pathway in parvalbumin interneurons mediates the response to chronic antidepressants
por: Umschweif, Gali, et al.
Publicado: (2021) -
Ahnak scaffolds p11/Anxa2 complex and L-type voltage-gated calcium channel and modulates depressive behavior
por: Jin, Junghee, et al.
Publicado: (2019)